AI-powered cancer diagnosis company raises $55M

Ibex Medical Analytics, an artificial intelligence-powered cancer diagnostics, raised $55 million in series C financing.

Ibex’s Galen platform integrates AI into pathologists’ workflows. The platform has gone live at Pittsburgh-based UPMC, according to a Sept. 6 Ibex news release. The Israeli company will use the funding to expand further into the U.S.

Venture capital firm 83North led the funding round. The financing brought Ibex’s total capital raised to over $100 million.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars